A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Life Expectancy for Young People With HIV Is Nearly Normal
Failure to Awaken Dormant Cells Deals Blow to HIV Cure Research
Scientists Devise Method of Snipping HIV From Immune Cells
Media Cooks Up Claim That Soy Sauce Treats, Even Cures HIV
FDA Approves New Single-Tablet HIV Regimen, Triumeq
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

July 18, 2013

HPV Vaccine Could Reduce Anal Cancer Rates in Older Gay Men

Human papillomavirus (HPV) vaccines, given to older gay men, could prevent the transmission of strains of the virus that lead to anal cancer, aidsmap reports. Between 2010 and 2013, Australian researchers studied 342 gay men ages 35 or older who were tested at the outset for the strains of HPV covered by the currently available Gardasil vaccine and by the vaccine in development by Merck. They presented their findings at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.

Anal cancer is particularly prevalent among HIV-positive gay men, who have a rate of 100 cases per 100,000 people.

The study population had a median age of 49, with a range of 35 to 79. Twenty-nine percent of them were HIV positive. Over a three-year follow-up period, the participants were tested for new high-risk HPV infections.

At the study’s outset, 51 percent of the men were infected with a Gardasil-covered strain of HPV and 27 percent with the Merck vaccine-covered strains. Each year of the study, one in five men became newly infected with a strain covered by Gardasil and 27 percent with a strain covered by Merck’s vaccine.

Having HIV was linked both to infection with cancer-causing HPV at the study’s outset and to new infections with those strains during the follow-up period. There was no correlation between age and likelihood of HPV infection.

To read the aidsmap story, click here.

Search: HPV, vaccine, Gardasil, anal cancer, aidsmap, human papillomavirus, th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Merck & Co.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    charliehunter
    San Francisco
    California


    usuallyhappy
    Palm Springs
    California


    ernienyc
    Bronx
    New York


    HOTROD2010
    houston
    Texas
Click here to join POZ Personals!
Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.